BNET Industries
Last Fiscal Year Sales:$37.5M
- Public
- UK
Dow Jones Description
Genetic Research Equipment & Supplies Mfr; Research Services for Life Sciences & Pharmaceutical Development
Number of Employees 181
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
News & Analysis
Filter by
gtx inc. - All News and Analysis
GTx Inc Q4 2008 Earnings Call Transcript
Earnings Call ExcerptGTx Inc GTXI Q4 2008 Earnings Call February 17, 2009; 09:00 am ET Executives Mitchell Steiner - Vice Chairman and Chief Executive Officer Marc Hanover - President and Chief Operating Officer Mark Mosteller - Chief Financial Officer McDavid Stilwell - Director of Corporate Communications...
GTx, Inc. Q3 2008 Earnings Call Transcript
Question-and-Answer Session Operator Operator instructions And your first question comes for the line of Joel Sendek of Lazard Capital Markets. Please proceed. Joel Sendek – Lazard Capital Markets Thanks. Good morning. My question has to do with your discussions with the FDA, we’ve heard someone on some...
GTx, Inc. Q2 2008 Earnings Call Transcript
Question-and-Answer Session Operator Operator instructions And your first question comes from the line of Joel Sendek with Lazard Capital Markets. Please proceed. Joel Sendek – Lazard Capital Markets Hi, thanks a lot. So – I have two questions. The first is on the filing. I was expecting filing a...
GTx Inc. Q1 2008 Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions Your first question comes from the line of Joel Sendek of Lazard Capital Markets. Please proceed. Joel Sendek - Lazard Capital Markets Thanks. I wanted to further define the couple of potential snares for the PIN trial. So, first of all, I want to understand...
GTx Q4 2007 Earnings Call Transcript
Question-and-Answer Session Operator Operator Instructions Please hold while we compile a list of questions. Your first question comes from the line of Eric Schmidt from Cowen & Company. Please proceed. Eric Schmidt – Cowen & Company Can I ask a question on ACAPODENE not related...
Hana Biosciences Receives Orphan Drug Designation for Ropidoxuridine (IPdR), for the Treatment of Malignant Glioma and GTx, Inc. to Present at Goldman Sachs Twenty-Seventh Annual Global Healthcare Conference.
M2 PRESSWIRE-9 June 2006-U.S. Equity News: Hana Biosciences Receives Orphan Drug Designation for Ropidoxuridine IPdR, for the Treatment of Malignant Glioma and GTx, Inc. to Present at Goldman Sachs Twenty-Seventh Annual Global Healthcare ConferenceC1994-2006 M2 COMMUNICATIONS LTD RDATE:09062006 City of...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Charles de Rohan | CEO |
| Andrew Kellett | Finance Director |
| Julian Burke | Scientific Director |
| Terry Pizzie | Director, Commercial Operations, Global |
| Hilary Latham | Manager, Marketing |
| Simon Hedger | Secretary |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| James Hill | Chairman |
| Mark Reid | Board of Directors |
| Peter Jensen | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Genetix Group PLC | CEO | Current |
| Genetix Group PLC | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Genetix Group PLC | Finance Director | Current |
| Genetix Group PLC | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Genetix Group PLC | Scientific Director | Current |
| Genetix Group PLC | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Genetix Group PLC | Director, Commercial Operations, Global | Current |
| Genetix Group PLC | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Genetix Group PLC | Manager, Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| Genetix Group PLC | Secretary | Current |
| Organization | Position | Status |
|---|---|---|
| Genetix Group PLC | Chairman | Current |
| Organization | Position | Status |
|---|---|---|
| Genetix Group PLC | Board of Directors | Current |
| Genetix Group PLC | CEO | Former |
| Organization | Position | Status |
|---|---|---|
| Genetix Group PLC | Board of Directors | Current |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- The 10 Weirdest Drug Stories of the Month 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes

